Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2009 3
2010 7
2011 4
2012 1
2013 5
2014 5
2015 4
2016 8
2017 5
2018 5
2019 8
2020 19
2021 40
2022 41
2023 21
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

175 results

Results by year

Filters applied: . Clear all
Page 1
mRNA-1273 vaccinated inflammatory bowel disease patients receiving TNF inhibitors develop broad and robust SARS-CoV-2-specific CD8+ T cell responses.
van den Dijssel J, Duurland MC, Konijn VA, Kummer LY, Hagen RR, Kuijper LH, Wieske L, van Dam KP, Stalman EW, Steenhuis M, Geerdes DM, Mok JY, Kragten AH, Menage C, Koets L, Veldhuisen B, Verstegen NJ, van der Schoot CE, van Esch WJ, D'Haens GR, Löwenberg M, Volkers AG, Rispens T, Kuijpers TW, Eftimov F, van Gisbergen KP, van Ham SM, Ten Brinke A, van de Sandt CE; T2B! immunity against SARS-CoV-2 study group. van den Dijssel J, et al. J Autoimmun. 2024 Apr;144:103175. doi: 10.1016/j.jaut.2024.103175. Epub 2024 Feb 21. J Autoimmun. 2024. PMID: 38387105 Free article.
Systematic evaluation of B-cell clonal family inference approaches.
Balashova D, van Schaik BDC, Stratigopoulou M, Guikema JEJ, Caniels TG, Claireaux M, van Gils MJ, Musters A, Anang DC, de Vries N, Greiff V, van Kampen AHC. Balashova D, et al. Among authors: van gils mj. BMC Immunol. 2024 Feb 8;25(1):13. doi: 10.1186/s12865-024-00600-8. BMC Immunol. 2024. PMID: 38331731 Free article.
Long trimer-immunization interval and appropriate adjuvant reduce immune responses to the soluble HIV-1-envelope trimer base.
Duan H, Corrigan AR, Cheng C, Biju A, Gonelli CA, Olia AS, Teng IT, Xu K, O'Dell S, Narpala S, Castro M, Serebryannyy L, Wang J, Parchment DK, Sarfo EK, van Schooten J, Todd JP, Wang S, Harris DR, Geng H, Jafari AJ; VRC Production Program; Woodward RA, Doria-Rose NA, Foulds KE, McDermott AB, van Gils MJ, Koup RA, Pierson TC, Kwong PD, Mascola JR. Duan H, et al. Among authors: van gils mj. iScience. 2024 Jan 11;27(2):108877. doi: 10.1016/j.isci.2024.108877. eCollection 2024 Feb 16. iScience. 2024. PMID: 38318357 Free PMC article.
The Impact of First-Time SARS-CoV-2 Infection on Human Anelloviruses.
Timmerman AL, Commandeur L, Deijs M, Burggraaff MGJM, Lavell AHA, van der Straten K, Tejjani K, van Rijswijk J, van Gils MJ, Sikkens JJ, Bomers MK, van der Hoek L. Timmerman AL, et al. Among authors: van gils mj. Viruses. 2024 Jan 9;16(1):99. doi: 10.3390/v16010099. Viruses. 2024. PMID: 38257799 Free PMC article.
Defining bottlenecks and opportunities for Lassa virus neutralization by structural profiling of vaccine-induced polyclonal antibody responses.
Brouwer PJM, Perrett HR, Beaumont T, Nijhuis H, Kruijer S, Burger JA, Lee WH, Müller-Kraüter H, Sanders RW, Strecker T, van Gils MJ, Ward AB. Brouwer PJM, et al. Among authors: van gils mj. bioRxiv [Preprint]. 2023 Dec 23:2023.12.21.572918. doi: 10.1101/2023.12.21.572918. bioRxiv. 2023. PMID: 38187682 Free PMC article. Preprint.
A panel of hepatitis C virus glycoproteins for the characterization of antibody responses using antibodies with diverse recognition and neutralization patterns.
Chumbe A, Grobben M, Capella-Pujol J, Koekkoek SM, Zon I, Slamanig S, Merat SJ, Beaumont T, Sliepen K, Schinkel J, van Gils MJ. Chumbe A, et al. Among authors: van gils mj. Virus Res. 2024 Mar;341:199308. doi: 10.1016/j.virusres.2024.199308. Epub 2024 Jan 11. Virus Res. 2024. PMID: 38171391 Free PMC article.
Into the Dark Serum Proteome: Personalized Features of IgG1 and IgA1 Repertoires in Severe COVID-19 Patients.
Bondt A, Hoek M, Dingess K, Tamara S, de Graaf B, Peng W, den Boer MA, Damen M, Zwart C, Barendregt A, van Rijswijck DMH, Schulte D, Grobben M, Tejjani K, van Rijswijk J, Völlmy F, Snijder J, Fortini F, Papi A, Volta CA, Campo G, Contoli M, van Gils MJ, Spadaro S, Rizzo P, Heck AJR. Bondt A, et al. Among authors: van gils mj. Mol Cell Proteomics. 2024 Jan;23(1):100690. doi: 10.1016/j.mcpro.2023.100690. Epub 2023 Dec 6. Mol Cell Proteomics. 2024. PMID: 38065436 Free PMC article.
Broad SARS-CoV-2 neutralization by monoclonal and bispecific antibodies derived from a Gamma-infected individual.
Guerra D, Beaumont T, Radić L, Kerster G, van der Straten K, Yuan M, Torres JL, Lee WH, Liu H, Poniman M, Bontjer I, Burger JA, Claireaux M, Caniels TG, Snitselaar JL, Bijl TPL, Kruijer S, Ozorowski G, Gideonse D, Sliepen K, Ward AB, Eggink D, de Bree GJ, Wilson IA, Sanders RW, van Gils MJ. Guerra D, et al. Among authors: van gils mj. iScience. 2023 Sep 22;26(10):108009. doi: 10.1016/j.isci.2023.108009. eCollection 2023 Oct 20. iScience. 2023. PMID: 37841584 Free PMC article.
Assessing immunogenicity barriers of the HIV-1 envelope trimer.
Maliqi L, Friedrich N, Glögl M, Schmutz S, Schmidt D, Rusert P, Schanz M, Zaheri M, Pasin C, Niklaus C, Foulkes C, Reinberg T, Dreier B, Abela I, Peterhoff D, Hauser A, Kouyos RD, Günthard HF, van Gils MJ, Sanders RW, Wagner R, Plückthun A, Trkola A. Maliqi L, et al. Among authors: van gils mj. NPJ Vaccines. 2023 Sep 30;8(1):148. doi: 10.1038/s41541-023-00746-3. NPJ Vaccines. 2023. PMID: 37777519 Free PMC article.
175 results